Accelerating the development of biomarkers for drug safety workshop summary /

Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary /
mā: Mack, Alison
I whakaputaina: (2011)

Biomarkers : medical and workplace applications /
I whakaputaina: (1998)

Evaluation of biomarkers and surrogate endpoints in chronic disease
I whakaputaina: (2010)

Developing biomarker-based tools for cancer screening, diagnosis, and treatment the state of the science, evaluation, implementation, and economics /
mā: Patlak, Margie
I whakaputaina: (2006)

Biomarkers in medicine, drug discovery, and environmental health /
I whakaputaina: (2010)

Neuroscience biomarkers and biosignatures converging technologies, emerging partnerships : workshop summary /
I whakaputaina: (2008)

Analysis of biomarker data : a practical guide /
mā: Looney, Stephen W., me ētahi atu.
I whakaputaina: (2015)

Challenges for the FDA the future of drug safety : workshop summary /
I whakaputaina: (2007)

Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : workshop summary /
mā: Patlak, Margie, me ētahi atu.
I whakaputaina: (2015)

Clinical trials study design, endpoints and biomarkers, drug safety, FDA and ICH guidelines /
mā: Brody, Tom
I whakaputaina: (2012)

Emerging safety science workshop summary /
I whakaputaina: (2008)

Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance /
mā: Turner, J. Rick
I whakaputaina: (2009)

Biomarkers for early diagnosis of Alzheimer's disease
I whakaputaina: (2008)

Residue evaluation of certain veterinary drugs : Joint FAO/WHO Expert Committee on Food Additives, 75th meeting, Rome, Italy, 8-17 November 2011.
I whakaputaina: (2012)

Statistical methods for evaluating safety in medical product development /
I whakaputaina: (2015)

Biomarkers and occupational health progress and perspectives /
I whakaputaina: (1995)

Promoting safety of medicines for children
I whakaputaina: (2007)

Adverse drug event reporting the roles of consumers and health-care professionals : workshop summary /
I whakaputaina: (2007)

Osteoarthritis, inflammation and degradation a continuum /
I whakaputaina: (2007)

Biologic markers in immunotoxicology
I whakaputaina: (1992)

The future of drug safety promoting and protecting the health of the public /
I whakaputaina: (2007)

Control and the therapeutic trial rhetoric and experimentation in Britain, 1918-48 /
mā: Edwards, Martin, 1955 Nov. 23-
I whakaputaina: (2007)

Drug discovery and development for Alzheimer's disease 2000
I whakaputaina: (2002)

Biologic markers in reproductive toxicology
I whakaputaina: (1989)

European studies on drugs and drug policy : selected readings from the 14th International Conference of the European Society for Social Drug Research (ESSD) /
I whakaputaina: (2004)

Drug design cutting edge approaches /
I whakaputaina: (2002)

Applications of polymers in drug delivery /
I whakaputaina: (2014)

Pharmaceutical drug analysis methodology - theory - instrumentation - pharmaceutical assays - cognote assays.
mā: Kar, Ashutosh
I whakaputaina: (2005)

Drug concentrations in neuropsychiatry
I whakaputaina: (1980)

Manual of biological markers of disease
I whakaputaina: (1996)

Understanding the benefits and risks of pharmaceuticals workshop summary, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy /
I whakaputaina: (2007)

Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)

Detection and prevention of adverse drug events information technologies and human factors /
I whakaputaina: (2009)

Drug discovery and design medical aspects /
I whakaputaina: (2002)

Evaluation of certain veterinary drug residues in food sixty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives.
I whakaputaina: (2006)

Biologic markers in pulmonary toxicology
I whakaputaina: (1989)